Ventavia Research Group is a clinical research site located in Fort Worth, Texas, United States 76104.
Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.
Ventavia Research Group has participated in 33 clinical trials.
Therapeutic areas: Respiratory Tract Infections, Episodic Migraine, Clostridium Difficile Associated Disease.
Sponsors: Pfizer, Allergan, Merck Sharp & Dohme LLC.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Fort Worth
Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Ventavia Research Group has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ventavia Research Group has 33 clinical trials on record. Their work covers Respiratory Tract Infections, Episodic Migraine, Clostridium Difficile Associated Disease.
Ventavia Research Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.